Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Companies Must Adjust To Growth Of Outpatient Centers, ZS Consultant Advises

Executive Summary

The medtech industry has been slow to adapt to the rapid growth of lower-cost outpatient centers that are taking procedures out of hospitals, according to Brian Chapman, a consultant for ZS.

You may also be interested in...



Podcast Special: J&J's Andrie Leday Addresses ASC Market With Customized Approach

In this special podcast from Medtech Insight, editor Reed Miller talked to Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes. Leday's group is dedicated to creating a new "ecosystem" around DePuy Synthes' broad range of orthopedic implants and tools to meet the demand of an aging population.

Medtech CEOs Predict Diminished Role For Hospitals In The Future Of Surgery

Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.

Interview: How Medtech Companies Are Preparing To Navigate Post-Pandemic Market

In an interview with Medtech Insight, ZS consultant Brian Chapman explains how medtech companies are handling the uncertainties created by the pandemic and how it could change the industry permanently.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel